The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Ireland
1-10 Employees
2009
MyBio is the exclusive supplier of many of the world’s leading bioscience products. MyBio give you easy access to Proteintech’s extensive range of high quality and competitively priced antibodies, cytokines, and other essential research products. A trusted provider of bespoke commercial solutions to partners and customers. Delivering innovative leading edge technologies into the Irish market to enable new discoveries in life sciences. It has the largest proprietary portfolio of self-manufactured antibodies, covering 2/3 of the human proteome. With over 200,000 products cited and confirmed specificity, Proteintech offers antibodies and immunoassays across a wide range of research areas. Proteintech supply over 15,000 products against 13,000 different proteins. This selection currently covers 2/3 of the human proteome and is self manufactured and validated for reproducibility, creating unparalleled quality and uninterrupted supply.
+
Featured
Recombinant NAP1L1 protein
... Recombinant NAP1L1 protein for chromatin assembly and protein-protein interaction in vitro. ...
Oxford, United Kingdom
1-10 Employees
2022
We deliver a service starting from hybridoma creation from your selected antigen, through screening and culture, to purification of the chosen clones. Each part of our service can be utilised independently, such as growth and/or purification of your own hybridoma, or conjugation of your own antibody or one chosen from our own range. Our goal is to be recognised for the science we do and to have a track record of success for our clients. We provide complete cost-effective services for the development and production of antibodies. Fagus Antibody Services is made up of a team of experienced scientists to provide a complete package in antibody development.
+
Featured
Recombinant Mouse CXCL9 Protein
... Recombinant Mouse CXCL9 Protein - Fagus Antibody ...
Candler, United States
1-10 Employees
2021
Gelacell™ is a non-woven, highly porous scaffold specially designed for in vitro 3D cell culture and tissue engineering. Gelacell™ offers exceptional biocompatibility and non-toxicity across a variety of cell types. The CellScrew® is a novel single-use cell culture device with a high growth area to volume ratio. It is made from plant derived polylactic acid (PLA) by an additive manufacturing process. Ilex Life Sciences offers a carefully curated selection of unique, novel, and high-quality immunoassay kits from trusted manufacturers around the world.
+
Featured
Endostatin Human Recombinant Protein
... Our bioactive Human Endostatin E. coli Recombinant Protein is provided as sterile-filtered liquid solution formulated with 30mM Sodium acetate buffer and Mannitol, pH-5.5. Purity greater than 95.0% (SDS-PAGE). Endostatin has been shown to act as a potent inhibitor of angiogenesis and tumor ...
Memphis, United States
1-10 Employees
2012
Our mission is to develop and license vaccines and immunodiagnostic assays to help mitigate the impact of these diseases in human and animal health. With our main focus in Lyme diseases and Leptospirosis, we develop and license vaccines and diagnostic assays to help mitigate the impact of these diseases on human and animal health.As our products mature from the laboratory to the next early stages of development, our long-term goal is to seek strategic alliances with partners who are capable of commercializing new biological products.
+
Featured
OspA Recombinant Protein
... OspA Recombinant Protein – Immuno Technologies, Inc. ...
Dubuque, United States
1-10 Employees
1978
Our reliable products and customer-first service are here for your discovery journey. We believe trust between a researcher and their product supplier is built through consistent products and excellent customer service. If you aren’t 100% satisfied with your product purchase, no matter the issue, we will make it right. Whether your business is a one-room lab startup or a pharmaceutical enterprise, IBI Scientific is here for you. When you’re ready to purchase your life science research products, create a free IBI Scientific account and receive 25% off your entire order plus free U.S. IBI Scientific is an ISO 9001:2015 certified manufacturer and international provider of life science research equipment and reagents.
+
Featured
Recombinant Mouse Protein TNFSF11
... Recombinant Mouse Protein | Cell Culture | IBI ...
Richmond, United States
51-100 Employees
2001
Founded in 2001., ProMab Biotechnologies develops and commercializes recombinant proteins, antibodies, and engineered cell lines through the integration of bioinformatics, molecular biology, protein expression, purification techniques, gene cloning, microbiology, and immunology, using novel high-throughput technologies. ProMab provides its proprietary proteins, engineered cell lines, and antibodies to deliver innovative research and diagnostic products, as well as services for the global biomedical research community through collaborations, partnerships, and joint ventures with other biotechnology and bio-reagent companies. ProMab has also developed a novel mRNA lipid nanoparticle (mRNA-LNP) platform for ready-to-use reagents and custom research services to advance the current offerings and expand to more fields of research. ProMab is on target to be one of the leading suppliers of bio-reagents in the twenty-first century and is committed to improving human health with a focus on the field of immunotherapy, specifically CAR-T/NK cell technologies. Since 2001, ProMab has built in-house expertise in the latest technologies to help our partners push the frontiers of medicine. Today, we are the only provider that can offer CAR-T/NK development, mRNA-LNP development, and antibody engineering-highly promising technologies on their own and even more powerful when combined. Leverage our validated platform to advance your studies into the use of LNP-based delivery of mRNAs, including the development of vaccines, engineered immune cells, or antibody-encoding mRNA solutions.
+
Featured
Cyp2d6 Recombinant Protein for Research
... Cyp2d6 Recombinant Protein for Research | ...
Mannheim, Germany
1-10 Employees
The Q-bios GmbH was founded in 2009 to provide products and services for the life sciences including the biotechnology, pharmaceutical and diagnostic industry. Q-bios’ expertise is the production of recombinant peptides, antigens and other proteins, which we offer to other companies in bulk amounts and as OEM. Q-bios GmbH is your specialist for recombinant protein and enzyme production. We produce various DNA polymerases and PCR mastermixes – for routine applications or custom designed specifically for your needs. Our purpose: Providing the best products and consultancy for your goals in the life sciences. Aside from this, we specialized on the production and distribution of PCR related reagents. Our PCR products can be purchased by companies in large quantities tailored to their needs. PCR products are also marketed for end consumers by distributors in different countries.
+
Featured
Recombinant Proteins
... Recombinant Proteins / Q-bios ...
Versailles, United States
1-10 Employees
2004
We manufacture and test all of our antibody tools In-House. Our products are sold to scientists in the U.S. We are excited to announce that we have joined forces with PhosphoSolutions, and are moving operations to Aurora, Colorado for 2023. ECM Biosciences was founded in the Bluegrass region of Kentucky. The founders of ECM Biosciences each have over 25 years experience in antibody manufacturing, distribution, and sales. Mike has over 25 years experience with mouse monoclonal and rabbit polyclonal antibody manufacturing, as well as extensive experience with research reagent distribution and sales.
+
Featured
Prion Recombinant Protein
... Prion Recombinant Protein – ECM ...
Poway, United States
11-50 Employees
1998
ProSci Incorporated is a privately-held biotechnology firm located in San Diego, California doing business for over 20 years. A leader in its field, ProSci’s priority is to provide the highest quality monoclonal, polyclonal, and recombinant antibody products and services in the industry. ProSci’s expertise in antibody development, production, and biological research is realized through customizable services, innovative products, competitive pricing, high-quality research tools, and unparalleled technical support. ProSci Incorporated specializes in the production of affinity-purified peptide-specific polyclonal antibodies to novel antigens in fields such as HIV. Many of the polyclonal research antibodies offered by ProSci are affinity-purified, which allows for the isolation of antibodies specific to the epitope of interest. In addition, ProSci offers a complete assortment of reagents for immunochemical assays, including cell line lysates, tissue lysates and peptides as controls for these antibodies. ProSci’s innovative research approach using genetically engineered yeast strain and glycoproteins to mimic the HIV-1 glycan coat and develop neutralizing antibodies against HIV-1 glycans has been awarded several Small Business Innovative Research (SBIR) grants by NIH. ProSci’s custom antibody services specialize in polyclonal, monoclonal, and recombinant rabbit monoclonal and recombinant llama single domain antibody development and production.
+
Featured
FGF-23 Recombinant Protein - Cat. No. 40-709 | ProSci
... FGF-23 Recombinant Protein - Cat. No. 40-709 | ...
Cambridge, United Kingdom
11-50 Employees
2016
Qkine is committed to manufacturing bioactive proteins of the highest quality to enhance scientific outcomes and improve reproducibility. Qkine combines proprietary production processes with protein engineering technology to tackle fundamental biological, quality, and scale-up challenges. Our goal is to provide the highest purity, bioactive proteins for research and bio-manufacturing to best support our customers and maximize the impact of their science. Qkine is an ISO9001: 2015 certified company with an established global distribution network. Qkine has provided us with exceptional customer service and most importantly top-quality, affordable growth factors. Qkine staff are communicative and efficient and delivery times are excellent.”. Qkine is delighted to announce a new collaboration with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus. Qkine is delighted to announce its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.
+
Featured
Recombinant human SCF protein (Qk078)
... Human recombinant SCF protein | Animal-free | ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Recombinant Protein
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 189 |
| Amount of suitable service providers | 146 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1978 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
A recombinant protein is a complex molecule engineered through the genetic manipulation of DNA to produce proteins that do not naturally occur or are produced in insufficient quantities. This process involves the insertion of a specific gene encoding the desired protein into a plasmid, which is then introduced into a host organism, such as bacteria, yeast, or mammalian cells. The host organism's cellular machinery is co-opted to synthesize the protein, which can then be isolated and purified for various applications. The production of recombinant proteins has revolutionized the field of biotechnology, enabling the mass production of proteins for research, therapeutic, and industrial purposes. For instance, it has facilitated the development of novel vaccines and medicines, including insulin and growth hormones, significantly impacting healthcare by providing treatments for diseases that were previously difficult to manage. In the research domain, recombinant proteins serve as invaluable tools in studying protein structure and function, contributing to our understanding of complex biological processes and disease mechanisms. Furthermore, in the industrial sector, these proteins are used to enhance the efficiency of manufacturing processes, such as in the production of biofuels and in waste management. The versatility and wide-ranging applications of recombinant proteins underscore their pivotal role in advancing scientific and medical research, improving patient care, and supporting sustainable industrial practices.
1. High Specificity and Purity
Recombinant proteins offer unparalleled specificity and purity compared to proteins derived from natural sources. This advantage stems from their production in controlled environments where conditions are optimized for the expression of the target protein, minimizing contaminants and by-products.
2. Scalability and Consistency
The production of recombinant proteins can be easily scaled up to meet increasing demands without sacrificing quality. This scalability ensures a consistent supply of high-quality proteins, crucial for research, therapeutic, and industrial applications.
3. Customization and Versatility
Recombinant DNA technology allows for the modification and customization of proteins, enabling the creation of variants with improved stability, solubility, or activity. This versatility supports the development of optimized proteins for specific applications, ranging from medical treatments to industrial enzymes.
4. Reduced Risk of Contamination
By producing proteins in a controlled laboratory setting, recombinant protein technology significantly reduces the risk of contamination with pathogens or endotoxins that are often associated with proteins extracted from animal or human tissues. This feature is particularly important in the production of pharmaceuticals and therapeutic agents.
While evaluating the different suppliers make sure to check the following criteria:
1. Production Capacity
Ensure the supplier can meet your demand, considering both current needs and potential future growth.
2. Purity Levels
Verify that the recombinant proteins offered meet high purity standards, as this affects the quality and reliability of your experiments.
3. Quality Control Processes
Look for suppliers with robust quality control measures, including batch-to-batch consistency and transparent documentation of their procedures.
4. Customization Options
Determine if the supplier can provide customized solutions, such as specific protein tags or expression systems, tailored to your research needs.
5. Technical Support
Assess the level of technical support offered, including access to scientists and customer service responsiveness, to ensure smooth troubleshooting and product utilization.
6. Cost Effectiveness
While not compromising on quality, consider the pricing and the overall cost-effectiveness of the supplier's offerings in relation to your budget constraints.
7. Reputation and Reviews
Research the supplier's reputation within the scientific community, including peer reviews and testimonials, to gauge reliability and customer satisfaction.
Recombinant proteins, engineered through biotechnology, are pivotal in the pharmaceutical industry, especially in drug development and production. They serve as essential components in creating medications for diseases like diabetes, cancer, and hemophilia, where traditional treatment methods fall short. Their customizable nature allows for targeted therapies, offering higher efficacy and reduced side effects compared to conventional drugs. In the field of diagnostics, recombinant proteins play a crucial role as well. They are used to develop diagnostic assays and kits that can detect various diseases with high specificity and sensitivity. These proteins can mimic disease markers, enabling early and accurate detection which is vital for effective treatment planning. The agriculture sector also benefits from recombinant protein technology, particularly in developing pest-resistant crops and enhancing nutritional profiles. By incorporating specific proteins into plants, it’s possible to increase crop yield, reduce dependency on chemical pesticides, and improve the nutritional value of the produce, addressing food security and public health issues. In research and development, recombinant proteins are indispensable tools. They facilitate the study of protein interactions, functions, and structures, significantly advancing our understanding of biological processes and disease mechanisms. This deepened knowledge aids in the discovery of novel therapeutic targets and the development of innovative treatment strategies, pushing the boundaries of science and medicine.
Recombinant protein technology, a cornerstone in biotechnology and pharmaceutical industries, has advanced to a high Technology Readiness Level (TRL), generally situated between TRL 8 and TRL 9. This classification reflects the technology's extensive validation in real-world conditions and its successful integration into commercial applications. The journey to this TRL has been underpinned by rigorous scientific research and development. Over the years, technical refinements in gene cloning, expression systems, and purification techniques have significantly enhanced the yield, purity, and functionality of recombinant proteins. These advancements have enabled the production of a wide array of proteins, from insulin to monoclonal antibodies, with applications in disease treatment, vaccine development, and diagnostics. The high TRL is also indicative of the robust regulatory frameworks that have been established, ensuring the safety and efficacy of recombinant protein-based products. Furthermore, the scalability of production methods has been optimized, allowing for the high-volume manufacturing required to meet global demands. The technical maturity of recombinant protein technology is a testament to its reliability and the pivotal role it plays in modern medicine and biotechnology.
In the Short-Term, advancements in recombinant protein technology are poised to enhance the efficiency of protein production systems. Techniques like CRISPR and advanced gene editing are expected to play a significant role, enabling more precise modifications of DNA sequences for protein expression. This phase will likely see an increase in the yield and purity of recombinant proteins, reducing costs and time in pharmaceutical and research applications. Moving into the Mid-Term, the focus will shift towards improving the scalability and sustainability of recombinant protein production. Bioreactors and fermentation processes will undergo innovations, allowing for large-scale production that meets the growing demand in various industries, from pharmaceuticals to agriculture. This period will also witness the integration of artificial intelligence and machine learning for optimizing production processes, predicting protein structure and function, and customizing proteins for specific therapeutic applications. In the Long-Term, the horizon will expand to include the development of entirely novel protein structures with unprecedented functions, thanks to recombinant technology. These advancements will pave the way for revolutionary applications in medicine, such as targeted drug delivery systems, bespoke therapies, and regenerative medicine. Additionally, the environmental impact of protein production will be significantly reduced, with innovations aimed at using renewable resources and minimizing waste, aligning with global sustainability goals.
Some interesting questions that has been asked about the results you have just received for Recombinant Protein
What are related technologies to Recombinant Protein?
Based on our calculations related technologies to Recombinant Protein are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Recombinant Protein?
Start-Ups who are working in Recombinant Protein are Fagus Antibody Services
,
Ilex Life Sciences LLCWhich industries are mostly working on Recombinant Protein?
The most represented industries which are working in Recombinant Protein are Biotechnology, Science and Engineering, Health Care, Manufacturing, Professional Services
How does ensun find these Recombinant Protein Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
